Back

The Apolipoprotein A2/Apolipoprotein C3 ratio predicts future cardiovascular events after percutaneous coronary intervention in patients receiving LDL-cholesterol-lowering therapy

28 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Novel biomarkers in patients with acute and chronic coronary syndromes: from bench to bedside Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Hideki Usuda

(Japan)

6 More presentations in this session

Presentation thumbnail
The new 6th generation high-sensitivity troponin T identifies increased risk of perioperative mortality and major cardiovascular events in noncardiac surgery
Doctor F. Borges (Hamilton, CA)
Abstract Slides
Presentation thumbnail
Superiority of the SUA/eGFR Ratio in predicting early hard events in STEMI: A large-scale head-to-head comparison and J-shaped risk discovery
Professor K. Chen (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Enhanced risk for recurrent adverse cardiovascular events in homozygous carriers of the T-allele of CD40 SNP rs1883832
Doctor M. Gissler (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
The predictive value of C-reactive protein-triglyceride-glucose index and clonal hematopoiesis of indeterminate potential among patients with STEMI---from a prospective cohort study
Doctor X. Zhao (Beijing, CN)
Abstract Slides
Presentation thumbnail
Plasma Infrared Fingerprinting Identifies Residual Risk in Coronary Artery Disease and Captures Clonal Haematopoiesis-Associated Biology
Doctor M. von Scheidt (Munich, DE)
Abstract Slides

Access the full session

Session thumbnail
Novel biomarkers in patients with acute and chronic coronary syndromes: from bench to bedside

The Event

Event poster

ESC Congress 2026

28 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
High apo-CIII level correlates with poor lipid status, pro-inflammatory and fibrotic biomarker profile, and adverse cardiovascular outcome in patients with recent acute coronary syndrome
30 August 2025
thumbnail
Congress Presentation
Association of baseline and longitudinal changes in non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio with cardiovascular outcomes in peripheral artery disease
30 August 2025
thumbnail
Congress Presentation
Cardiorenal stress phenotyping using the log-transformed bun-to-ejection fraction ratio improves prediction of recurrent ischemic events in young patients with acute coronary syndrome
28 August 2026
thumbnail
Congress Presentation
Elevated AST/ALT ratio predicts future cardiovascular events in high-risk diabetic patients without a history of cardiovascular disease
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources